跳至主要内容
临床试验/EUCTR2014-004742-10-DK
EUCTR2014-004742-10-DK进行中(未招募)1 期

The effect of 0,9% NaCl on the kidney function, vasoactive hormones, biomarkers and glycosaminglycanes in plasma in patients operated on for primary hiparthrosis. - 0,9% NaCl effect on kidney function and glycocalyx in patients operated on for primary hiparthrosis

Department of medical Research, Regional Hospital Holstebro0 个研究点开始时间: 2014年11月12日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Alder > 18 year
  • Indication for ucementeret primary hiparthroplasty
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • Blooddonation or transfusion during the last month
  • Not willing to participate
  • estimated GFR below 30ml/min
  • type 1 diabetes

研究者

发起方
Department of medical Research, Regional Hospital Holstebro

相似试验

The effect of 0,9% SodiumChloride on the kidney... | 临床试验